Fundamentals of endothelial function for the clinical cardiologist

Circulation

Volumn 105, Issue 5, 2002, Pages 546-549

  Verma, Subodh ^a   Anderson, Todd J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Cardiovascular diseases; Endothelium; Physiology

Indexed keywords

ADRENOMEDULLIN; ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; BRADYKININ; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIN 2; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTACYCLIN; PROSTAGLANDIN H2; SOMATOMEDIN; THROMBOPLASTIN; THROMBOXANE A2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; HOMEOSTASIS; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM;

ADULT; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NITRIC OXIDE;

EID: 0037022256     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0502.104540     Document Type: Review

References (20)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
2. The L-arginine-nitric oxide pathway
3. Tetrahydrobiopterin: A critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?
4. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
5. Insulin action in the vasculature: Physiology and pathophysiology
6. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
7. Primary endothelial dysfunction: Atherosclerosis
8. Atherosclerosis - An inflammatory disease
9. Current concepts of the pathogenesis of the acute coronary syndromes
10. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
11. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
12. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
13. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dys-function in patients with coronary artery disease: The TREND (Trial on Reversing Endothelial Dysfunction) study
14. Assessment and treatment of endothelial dysfunction in humans
15. The assessment of endothelial function in humans
16. Close relation of endothelial function in the human coronary and peripheral circulations
17. Improved endothelial function with metformin in type 2 diabetes mellitus
18. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
19. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
20. Modulation of C-reactive proteinmediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs